Sarcopenia

Sarcopenia and frailty, known as the modern “Giants of Geriatrics”, are two age-related syndromes that have garnered significant attention in the field. Sarcopenia is characterized by the progressive loss of skeletal muscle mass and loss of muscle function. While frailty is a clinical condition characterized by an excessive vulnerability of the individual to endogenous and exogenous stressors. Both syndromes are considered strong predictors of morbidity, disability, and mortality in older adults, and their prevalence varies across different regions and diagnostic tools. There is growing recognition of various risk factors associated with sarcopenia and frailty in older adults, including malnutrition, chronic disease, depression, sleep disorders, teeth loss and cognitive decline. And there is the reversibility of returning to a healthy state with appropriate interventions. Early intervention through exercise and nutrition can help mitigate the risks associated with sarcopenia and frailty, and both syndromes can be effectively managed, benefiting both older adults and their families, while also reducing dependence on healthcare and social services. To support early intervention and reduce disability and hospitalization rates among older adults, this research topic welcomes original research articles, reviews, and opinion pieces that explore the current prevalence, the influencing risk factors, and prediction models of age-related sarcopenia and frailty. Early identification and early intervention were important to reverse these geriatrics syndromes. In identifying approaches to accurately measure, assess, and improve sarcopenia and frailty, the research topic strives to further substantiate the significance of sarcopenia and frailty in the field of geriatrics medicine and public health.